Tue, 12 Mar 2019 16:35:20 GMT
Smith & Nephew to acquire Osiris Therapeutics
On Tuesday, Smith & Nephew, the UK medical products maker, announced it would acquire the US regenerative medicine developer, Osiris Therapeutics, in a deal valued at $660M, as it sought to boost the company's profit margins.